South Korea
· Delayed Price · Currency is KRW Access Bio Statistics
Total Valuation
Access Bio has a market cap or net worth of KRW 205.91 billion. The enterprise value is -87.18 billion.
| Market Cap | 205.91B |
| Enterprise Value | -87.18B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Access Bio has 33.81 million shares outstanding. The number of shares has increased by 0.24% in one year.
| Shares Outstanding | 33.81M |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | +17.04% |
| Owned by Insiders (%) | 3.37% |
| Owned by Institutions (%) | 0.18% |
| Float | 10.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.07 |
| PB Ratio | 0.33 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 5.57 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.84 |
Financial Position
The company has a current ratio of 11.32, with a Debt / Equity ratio of 0.12.
| Current Ratio | 11.32 |
| Quick Ratio | 9.85 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.72 |
| Interest Coverage | -9.94 |
Financial Efficiency
Return on equity (ROE) is -2.80% and return on invested capital (ROIC) is -3.26%.
| Return on Equity (ROE) | -2.80% |
| Return on Assets (ROA) | -3.11% |
| Return on Capital (ROIC) | -3.26% |
| Revenue Per Employee | 1.00B |
| Profits Per Employee | -154.97M |
| Employee Count | 101 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 2.05 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.78% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -47.78% |
| 50-Day Moving Average | 7,204.80 |
| 200-Day Moving Average | 7,407.30 |
| Relative Strength Index (RSI) | 35.03 |
| Average Volume (20 Days) | 170,926 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Access Bio had revenue of KRW 101.33 billion and -15.65 billion in losses. Loss per share was -454.32.
| Revenue | 101.33B |
| Gross Profit | 19.60B |
| Operating Income | -36.17B |
| Pretax Income | -25.00B |
| Net Income | -15.65B |
| EBITDA | -18.52B |
| EBIT | -36.17B |
| Loss Per Share | -454.32 |
Balance Sheet
The company has 370.38 billion in cash and 74.60 billion in debt, giving a net cash position of 295.79 billion or 8,747.99 per share.
| Cash & Cash Equivalents | 370.38B |
| Total Debt | 74.60B |
| Net Cash | 295.79B |
| Net Cash Per Share | 8,747.99 |
| Equity (Book Value) | 623.08B |
| Book Value Per Share | 18,348.02 |
| Working Capital | 400.86B |
Cash Flow
In the last 12 months, operating cash flow was -94.12 billion and capital expenditures -9.16 billion, giving a free cash flow of -103.28 billion.
| Operating Cash Flow | -94.12B |
| Capital Expenditures | -9.16B |
| Free Cash Flow | -103.28B |
| FCF Per Share | -3,054.49 |
Margins
Gross margin is 19.35%, with operating and profit margins of -35.70% and -15.45%.
| Gross Margin | 19.35% |
| Operating Margin | -35.70% |
| Pretax Margin | -24.67% |
| Profit Margin | -15.45% |
| EBITDA Margin | -18.28% |
| EBIT Margin | -35.70% |
| FCF Margin | -101.92% |
Dividends & Yields
This stock pays an annual dividend of 823.00, which amounts to a dividend yield of 13.51%.
| Dividend Per Share | 823.00 |
| Dividend Yield | 13.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.24% |
| Shareholder Yield | 13.27% |
| Earnings Yield | -7.46% |
| FCF Yield | -50.16% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Access Bio has an Altman Z-Score of 3.52.
| Altman Z-Score | 3.52 |
| Piotroski F-Score | n/a |